CHANGES IN INDICATORS OF ANTIOXIDANT PROTECTION IN CHRONIC ENTEROCOLITIS AND THEIR CORRECTION
DOI:
https://doi.org/10.32782/health-2023.1.8Keywords:
chronic enterocolitis, superoxide dismutase, catalase, antioxidant system, emoxipin, free radical oxidationAbstract
Chronic enterocolitis is one such disease, the basis of which is a combination of elements of inflammation and dystrophy of the mucous membrane with functional disorders of the small and large intestines. In the pathogenesis of enterocyte intoxication, the main role is played by oxidative stress, which is characterized by a violation of the metabolism of substances and energy, the accumulation of active damaging agents, initiating pathological changes in cells, and leading to the development of various pathological conditions. Therefore, our work aimed to determine the effectiveness of the use of antioxidant therapy (emoxipin) in experimental chronic enterocolitis in rats. The study was performed on 18 purebred white male rats, which were divided into 3 groups: the control group - 6 rats (intact animals), the 1st experimental group – 6 animals with chronic enterocolitis, the 2nd - 6 rats with chronic enterocolitis, which were subjected to emoxipin therapy. Chronic enterocolitis was reproduced by the free access of animals to a 1.0% solution of carrageenan in drinking water for 1 month. Animals with chronic enterocolitis were injected with 60 mg/kg of emoxipin intraperitoneally once a day for 10 days. Superoxide dismutase and catalase activity were determined in 10% homogenate of small intestine tissue. In the 1st experimental group, a significant decrease in superoxide dismutase activity by 42.7% and catalase by 57.9% (p<0.05) was noted, compared to the control. In the 2nd experimental group, the activity of SOD increased statistically significantly both about the control by 40.9% and about the 1st experimental group - by 146.8%, the activity of catalase was similar: about the control, it increased by 44.3%, in relatiaboutexperimental group – by 242.4% (р<0.05). Therefore, emoxipin is an effective drug of choice for chronic enterocolitis.
References
Oxidative stress and metabolism in animal model of colitis induced by dextran sulfate sodium / Damiani C. R., Benetton C. A., Stoffel С. et al. J. Gastroenterol. Hepatol. 2007. Vol. 22, № 11. P. 1846–1851. URL: https://doi.org/10.1111/j.1440-1746.2007.04890.x.
Kruidenier L., Verspaget H. W. Review article: oxidative stress as a pathogenic factor in inflammatory bowel disease--radicals or ridiculous? Aliment Pharmacol. Ther. 2002. Vol. 16, № 12. P. 1997–2015. URL: https://doi.org/10.1046/j.1365-2036.2002.01378.x.
Li X., Fang P., Mai J. Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers. J. Hematol. Oncol. 2013. Vol. 6. P. 1–19. URL: https://doi.org/10.1186/1756-8722-6-19.
Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis – a 6-month placebocontrolled trial / Lichtenstein G. R., Gordon G. L., Zakko S. et al. Aliment. Pharmacol. Ther. 2010. Vol. 32, № 8. Р. 990–999. URL: https://doi.org/10.1111/j.1365-2036.2010.04438.x.
Mesenchymal stem cells and conditioned medium avert enteric neuropathy and colon dysfunction in guinea pig TNBSinduced colitis / Robinson А. М., Sakkal S., Park А. et al. Am. J. Physiol. Gastrointest. Liver Physiol. 2014. Vol. 307, № 11. Р. G1115–G1129. URL: https://doi.org/10.1152/ajpgi.00174.2014.
Autoantibodies to GP2, the major zymogen granule membrane glycoprotein, are new markers in Crohn’s disease / Roggenbuck D., Reinhold D., Wex Т. et al. Clin. Chim. Acta. 2011. Vol. 412, № 9-10. P. 718–724. URL: https://doi.org/10.1016/j.cca.2010.12.029.
Мялюк О.П., Кліщ І.М., Заєць В.В. Порушення енергозабезпечення тканини печінки як один із механізмів аліментарного ожиріння. Наукові доповіді НУБіП України. 2016. № 58 (Лютий). URL: http://nd.nubip.edu.ua/2016_1/5.pdf.
Резніков О. Загальні етичні принципи експериментів на тваринах. Endokrynolohiya. 2003. № 8(1). P. 142–145.
Макаренко Е.В. Комплексное определение активности супероксиддисмутазы и глутатионредуктазы в эритроцитах у больных с хроническими заболеваниями печени. Лаб. дело. 1988. № 11. С. 48–50.
Королюк М.А., Иванова Л.И., Майоровап И.Г. Метод определения активности каталазы. Лаб. дело. 1988. № 1. С. 16–18.
Assessment of inflammatory markers in patients with diabetes mellitus and chronic hepatitis C virus infection / Skowronski M., Zozulinska D., Juszczyk J., Wierusz-Wysocka B. Diabetologia. 2004. Vol. 47(Suppl. 1). Р. A296.
